MEDVi QUAD Review – Stacking Three PDE5 Inhibitors Is Not an Upgrade

QUAD is MEDVi’s compounded “4-in-1” sublingual erectile dysfunction product, from $119 a month with a consultation included and, the company says, a 15-minute onset and a 36-hour window. Four active ingredients sounds like more medicine than one. In this case that is the problem rather than the selling point.

Three Drugs, One Mechanism

Combining drugs from different classes can be sound medicine, because they act on different targets. Combining three drugs from the same class does not add a new mechanism. It adds dose. You are not getting a cleverer treatment; you are getting more PDE5 inhibition, delivered by three molecules instead of one, with no trial evidence that this is better than an adequate dose of any single one.

The pharmacokinetics make it worse rather than better. Sildenafil and vardenafil are relatively short-acting, at roughly four to five hours. Tadalafil has a half-life around 17.5 hours, which is where the “36-hour window” claim comes from. Stacking them means a sharp early peak layered on top of a long tail — so if you do experience side effects such as headache, flushing, nasal congestion, visual disturbance or a drop in blood pressure, you cannot simply wait out a short-acting drug. Part of the dose is still with you the next day.

Apomorphine is the fourth component in that reported formulation, and it is a different mechanism — a centrally-acting dopamine agonist. It was developed for ED as Uprima and did not establish itself in the US market. Nausea and syncope are recognised effects. The alternative formulation some sources describe replaces it with PT-141 (bremelanotide), which is approved in the US only for hypoactive sexual desire disorder in premenopausal women, and would be off-label here.

Nobody Agrees What Is In It

This is its own finding. Some sources describe QUAD as sildenafil, tadalafil, vardenafil and apomorphine. Others describe sildenafil, tadalafil, PT-141 and L-citrulline. Those are materially different products with different risk profiles, and one of them contains an amino acid supplement where the other contains a third prescription PDE5 inhibitor.

Some of that may be genuine variation — compounded preparations can differ by pharmacy and by version, which is one of the standing objections to compounded products generally. But for a prescription drug combination, the buyer needs to know exactly which molecules and which doses they are being sold, before the first dose rather than after.

Get the formulation and per-ingredient doses in writing. If you take any other medication — particularly anything cardiovascular — take that written list to a pharmacist before you take a dose. This is the same argument we make about undisclosed doses in supplements, except the stakes are considerably higher when three of the ingredients are prescription vasodilators.

The “Independent” Reviews Are Not

A practical warning about researching this product. Searching for independent analysis of QUAD returns a large number of pages presenting themselves as clinical or medical-centre reviews, on domains that look like hospitals, urology practices or research consortia. Several are marketing content, and at least one prominent result is published by a direct competitor.

We are an affiliate site and we disclose it at the top of every page, which is the standard we think readers are owed. A page that reads like a medical centre and is actually a competitor selling you a rival ED product is a different thing. The company’s cited 4.9-star rating is also worth treating carefully — we could not verify it at source, and this is a category where review quality is unusually hard to assess.

ED Is Often the Symptom, Not the Problem

The reason is mechanical rather than mysterious. An erection is a vascular event, dependent on healthy endothelium — the lining of the blood vessels. Obesity drives endothelial dysfunction through inflammation, oxidative stress, raised blood pressure and insulin resistance. Treat that, and erectile function improves through the same pathway that improves everything else.

There is a hormonal route as well. Adipose tissue is rich in aromatase, which converts testosterone to estrogen, and the resulting estrogen suppresses the pituitary signal that tells the testes to make more. Weight loss of at least 10% has been associated with testosterone rises of roughly 55 to 115 ng/dL in clinical trials — covered further in our TRT review.

None of which means a PDE5 inhibitor is a bad idea. They work, they are well characterised, and nobody should be told to lose 30 pounds before they are allowed to have a sex life. It means the tablet manages the symptom while the cause continues, and if the cause is metabolic there is a treatment that addresses both. See our provider comparison, and our review of MEDVi’s weight-loss programme, which is the same company.

ED Can Be an Early Cardiac Warning

This is the single most important thing on the page. A man who buys a compounded ED product from a website, and whose symptom then resolves, may have quietly bypassed the cardiovascular assessment his symptom warranted. The problem does not go away because the erection came back.

If your ED is new, get blood pressure, lipids, HbA1c and testosterone checked by a clinician who is not selling you the treatment. That is a cheap set of tests and it is the difference between managing a symptom and finding out why you have it.

Pricing

From $119 a month, with a doctor consultation included and rush shipping advertised as free. Set against the alternative, that is the weakest part of the commercial case: generic sildenafil and generic tadalafil are among the cheapest prescription drugs available in the US, frequently under $20 a month, and both are FDA-approved finished products with known doses.

So the question is what the premium buys. Convenience and a consultation, genuinely. A novel combination with clinical evidence behind it — no. There is no trial showing the stack outperforms an adequately dosed single agent.

Pros and Cons

What We Would Do Instead

Start with a single agent. Generic sildenafil or tadalafil, properly dosed, is cheap, FDA-approved, and works for the large majority of men. If one does not suit you, the standard next step is to try the other or adjust the dose — not to take all of them at once.

Get the workup. New ED warrants blood pressure, lipids, HbA1c and testosterone, because of what it can be signalling.

Treat the cause if it is metabolic. If you carry excess weight, that is very likely part of the mechanism, and the evidence above suggests treating it does more for erectile function than a fourth ingredient will.

If you use QUAD anyway, get the exact formulation and doses in writing, check them with a pharmacist against everything else you take, and never combine it with nitrates.

Limitations of This Review

Based on the advertiser’s published claims and third-party coverage checked on 7 August 2026. We could not confirm the formulation at source, and independent sources conflict — the ingredient discussion here reflects what those sources report, not a verified label. We could not establish per-ingredient doses, which pharmacy compounds it, state availability, the screening process, cancellation terms, or verify the cited 4.9-star rating. Much of the available third-party coverage appears to be marketing content, including from a competitor, and we have weighted it accordingly. Evidence on GLP-1s, testosterone and erectile function comes from published research, not from MEDVi. Nothing here is medical advice — ED and its treatment need a clinician who knows your cardiovascular history.

Frequently Asked Questions

Verdict

More ingredients is not more medicine when the ingredients do the same thing. What the stack reliably adds is cost, overlapping duration and a compounded product whose contents independent sources cannot agree on.

The two things genuinely worth taking away: new ED can be an early cardiovascular signal and deserves a workup rather than a subscription, and if excess weight is part of the picture, the evidence now suggests treating that beats adding a fourth ingredient — in one head-to-head, it beat testosterone too.